IP Library Patent Application 13069258
Patent Application
App. No. 13/069,258

POLYMER COMPOSITIONS AND METHODS FOR THEIR USE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/069,258
Abstract

Compositions comprising anti-fibrotic agent(s) and/or polymeric compositions can be used in various medical applications including the prevention of surgical adhesions, treatment of inflammatory arthritis, treatment of scars and keloids, the treatment of vascular disease, and the prevention of cartilage loss.

Claims (13)

1 . A method for implanting a medical device comprising: (a) infiltrating a tissue of a host where the medical device is to be, or has been, implanted with a fluid composition comprising one or more of i) an anti-fibrotic agent, ii) an anti-infective agent, iii) a polymer or a compound that forms a polymer in situ, iv) a composition comprising an anti-fibrotic agent and a polymer, v) a composition comprising an anti-infective agent and a polymer, or vi) a composition comprising an anti-fibrotic agent, an anti-infective agent and a polymer, and (b) implanting the medical device into the host.

2 - 8540 . (canceled)

8541 . The fluid composition of claim 1 comprising i) an anti-fibrotic agent and ii) a polymer or a compound that forms a polymer in situ.

8542 . The fluid composition of claim 1 wherein the anti-fibrotic agent inhibits cell regeneration.

8543 - 8553 . (canceled)

8554 . The fluid composition of claim 1 wherein the anti-fibrotic agent is paclitaxel.

8555 - 8569 . (canceled)

8570 . The fluid composition of claim 1 wherein the anti-fibrotic agent is a fluoropyrimidine analogue.

8571 - 8617 . (canceled)

8618 . The fluid composition of claim 1 wherein the anti-fibrotic agent is sirolimus or an analogue or derivative thereof.

8619 - 8650 . (canceled)

8651 . The fluid composition of claim 1 wherein the anti-fibrotic agent is an endothelial growth factor receptor kinase inhibitor.

8652 - 8822 . (canceled)

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2014
From: ANGIOTECH INTERNATIONAL AG
To: IPXMEDICAL, LLC
Reel/Frame 034268/0799 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2014
From: HUNTER, WILLIAM L.; TOLEIKIS, PHILIP M.; GRAVETT, DAVID M.; MAITI, ARPITA; LIGGINS, RICHARD T.; TAKACS-COX, ANIKO; AVELAR, RUI; LOSS, TROY A.E.
To: ANGIOTECH INTERNATIONAL AG
Reel/Frame 034034/0892 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2014
From: GUAN, DECHI; WANG, KAIYUE
To: ANGIOTECH INTERNATIONAL AG
Reel/Frame 034034/0911 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2014
From: ANGIOTECH PHARMACEUTICALS, INC
To: IPXMEDICAL, LLC
Reel/Frame 032815/0107 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2014
From: ANGIOTECH PHARMACEUTICALS, INC.
To: IPXMEDICAL, LLC
Reel/Frame 032815/0138 →